In the BioHarmony Drug Report Database
Clistin, Karbinal Er (carbinoxamine) is a small molecule pharmaceutical. Carbinoxamine was first approved as Clistin on 1982-01-01. It is used to treat allergic conjunctivitis, allergic rhinitis perennial, angioedema, and vasomotor rhinitis in the USA. Carbinoxamine maleate’s patent is valid until 2029-03-29 (FDA).
Image (chem structure or protein)